ArticleThe Journal of clinical investigation2022

IFN-α with dasatinib broadens the immune repertoire in patients with chronic-phase chronic myeloid leukemia.

Jani Huuhtanen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.